Vanguard Group Inc Charles River Laboratories International, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,811,754 shares of CRL stock, worth $889 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,811,754

Previous 6,105,478 4.81%

Holding current value

$889 Million

Previous $919 Million 4.05%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$99.75 - $151.89 $29.3 Million - $44.6 Million	-293,724 Reduced 4.81%	5,811,754 $882 Million
Q1 2025 May 09, 2025	SELL	$150.52 - $190.14 $8.04 Million - $10.2 Million	-53,448 Reduced 0.87%	6,105,478 $919 Million
Q4 2024 Feb 11, 2025	BUY	$178.58 - $220.69 $10.8 Million - $13.4 Million	60,497 Added 0.99%	6,158,926 $1.14 Billion
Q3 2024 Nov 13, 2024	SELL	$187.96 - $245.29 $943,559 - $1.23 Million	-5,020 Reduced 0.08%	6,098,429 $1.2 Billion
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $11.8 Million - $15.3 Million	56,982 Added 0.94%	6,103,449 $1.26 Billion
Q1 2024 May 10, 2024	BUY	$203.52 - $273.43 $13.5 Million - $18.1 Million	66,161 Added 1.11%	6,046,467 $1.64 Billion
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $4.35 Million - $6.32 Million	26,446 Added 0.44%	5,980,306 $1.41 Billion
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $5.73 Million - $6.42 Million	29,482 Added 0.5%	5,953,860 $1.17 Billion
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $16.8 Million - $19.2 Million	-91,343 Reduced 1.52%	5,924,378 $1.25 Billion
Q1 2023 Jul 14, 2023	BUY	$191.89 - $259.92 $13,432 - $18,194	70 Added 0.0%	6,015,721 $1.21 Billion
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $11.3 Million - $15.3 Million	58,691 Added 0.99%	6,015,651 $1.21 Billion
Q4 2022 Feb 10, 2023	SELL	$197.11 - $250.07 $3.97 Million - $5.04 Million	-20,159 Reduced 0.34%	5,956,960 $1.3 Billion
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $1.29 Million - $1.78 Million	7,087 Added 0.12%	5,977,119 $1.18 Billion
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $7 Million - $10.4 Million	34,305 Added 0.58%	5,970,032 $1.28 Billion
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $17 Million - $24.1 Million	66,602 Added 1.13%	5,935,727 $1.69 Billion
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $18.6 Million - $23.7 Million	-52,925 Reduced 0.89%	5,869,125 $2.21 Billion
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $3.88 Million - $4.77 Million	10,416 Added 0.18%	5,922,050 $2.44 Billion
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $1.74 Billion - $2.2 Billion	5,911,634 New	5,911,634 $2.19 Billion

Others Institutions Holding CRL

# of Institutions

615

Shares Held

53.2M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.78B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Charles River Laboratories International, Inc. Transaction History